Financings in Brief: OrthoLogic
This article was originally published in The Gray Sheet
Executive Summary
OrthoLogic: Adopts shareholder rights plan under which one preferred stock purchase right is payable March 12 for each outstanding common stock share. Each right entitles the holder to purchase 1/100 of a share of Series A preferred stock for $25. The rights are exercisable in the event a person or group acquires 15% or more of the firm's stock or commences a tender offer for 20% or more of the firm. The rights expire on March 11, 2007...
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.